Cargando…

PTH Assays: Understanding What We Have and Forecasting What We Will Have

Parathyroid hormone (PTH) assays have evolved continuously for the last 50 years. Since the first radioimmunoassay was described in 1963, several assays based on immunological identification have been published (first generation assays). The routine assays used nowadays are immunometric “sandwich-ty...

Descripción completa

Detalles Bibliográficos
Autor principal:	Vieira, Jose Gilberto H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324155/ https://www.ncbi.nlm.nih.gov/pubmed/22548199 http://dx.doi.org/10.1155/2012/523246

Ejemplares similares

Artificial Intelligence in Urooncology: What We Have and What We Expect
por: Froń, Anita, et al.
Publicado: (2023)

Reversal Agents: What We Have and What We Can Expect
por: Ruff, Christian T.
Publicado: (2018)

What Shall We Have for Breakfast?
Publicado: (1890)

Lipoabdominoplasty: What We Have Implemented and What We Have Modified over 26 Years
por: Cárdenas-Camarena, Lázaro, et al.
Publicado: (2023)

Asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)

What have we learned?
por: Rodgers, Peter, et al.
Publicado: (2021)

Psychological Interventions for Dementia Caregivers: What We Have Achieved, What We Have Learned
por: Cheng, Sheung-Tak, et al.
Publicado: (2019)

Phage Therapy: What Have We Learned?
por: Górski, Andrzej, et al.
Publicado: (2018)

Severe COVID-19: what have we learned with the immunopathogenesis?
por: Bordallo, Bruno, et al.
Publicado: (2020)

Population Equation: Balancing What We Need With What We Have
por: Dahl, Richard
Publicado: (2005)

The calcium paradox - What should we have to fear?
por: de Oliveira, Marcos Aurélio Barboza, et al.
Publicado: (2014)

Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)

Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need
por: Liou, Geou-Yarh, et al.
Publicado: (2023)

Five decades of Fontan palliation: What have we learned? What should we expect?
por: Hassan, Adil, et al.
Publicado: (2023)

Endometriosis and Reproduction: What We Have Learned
por: Garcia-Fernandez, Jaime, et al.
Publicado: (2020)

SARS: What have we learned?
Publicado: (2003)

Orthopaedic infections: what have we learned?
por: Lee, Christopher, et al.
Publicado: (2023)

Robotic Prostatectomy: What We Have Learned and Where We Are Going
por: Lee, David I.
Publicado: (2009)

Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development
por: Delire, Bénédicte, et al.
Publicado: (2015)

GOAL: What Have We Learned?
por: Leek, Timothy K Vander
Publicado: (2005)

What have we learned on mesons?
por: Moebes, J P
Publicado: (1972)

Augmented Renal Clearance: What Have We Known and What Will We Do?
por: Luo, Yifan, et al.
Publicado: (2021)

Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?
por: Godoy, Luani Rezende, et al.
Publicado: (2022)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Genetics of rheumatoid arthritis: what have we learned?
por: Bax, Marieke, et al.
Publicado: (2011)

Drosophila Models of Tauopathies: What Have We Learned?
por: Gistelinck, Marc, et al.
Publicado: (2012)

What have we learned from brucellosis in the mouse model?
por: Grilló, María-Jesús, et al.
Publicado: (2012)

Toxoplasmosis vaccines: what we have and where to go?
por: Zhang, Yizhuo, et al.
Publicado: (2022)

Recent advances in pruritus - what we have learned and where are we headed
por: Yosipovitch, Gil
Publicado: (2010)

Defining transposition: What have we learnt?
por: Roderick, Max E., et al.
Publicado: (2021)

The multitubulin hypothesis revisited: what have we learned?
Publicado: (1987)

School Asthma Care During COVID-19: What We Have Learned and What We Are Learning
por: Abrams, Elissa M., et al.
Publicado: (2022)

INDIAN PSYCHIATRY AT THE CROSSROADS - WHAT WE CAN DO WITH WHAT WE HAVE?1
por: Channabasavanna, S.M.
Publicado: (1992)

MicroRNAs and cancer: what we know and what we still have to learn
por: Calin, George A
Publicado: (2009)

Erratum: asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)

Genetics of Obesity: What have we Learned?
por: Choquet, Hélène, et al.
Publicado: (2011)

Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need
por: Bidell, Monique R., et al.
Publicado: (2016)

COVID-19: what have we learned?
por: Ho, Yeh-Li, et al.
Publicado: (2020)

What have we learnt from Covid?
por: Salter, Mark Steven
Publicado: (2021)

COVID-19: What have we learned?
por: Rafalowski, Chaim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l11vkra48eacduhjskj6fp3du1